Cargando…
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
BACKGROUND: Breast cancer is the most common malignancy and the leading cause of cancer-related deaths among Jordanian women. With a median age of 50 years at diagnosis, a higher prevalence of hereditary breast cancer may be expected. The objective of this pilot study is to evaluate, for the first t...
Autores principales: | Abdel-Razeq, Hikmat, Al-Omari, Amal, Zahran, Farah, Arun, Banu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802063/ https://www.ncbi.nlm.nih.gov/pubmed/29409476 http://dx.doi.org/10.1186/s12885-018-4079-1 |
Ejemplares similares
-
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020) -
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022) -
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
por: Abu-Helalah, Munir, et al.
Publicado: (2020)